Search research articles
Contact Us
Filters
Showing results (131-140 of 204) with videos related to
Page
of 21
Sort By:
Journal of the Canadian Association of Gastroenterology
|
December 16, 2024
Acceptability, feasibility, and impact of the MyGut digital health platform in the monitoring and management of inflammatory bowel disease
Jamie Zhen, Maude Simoneau, Pooja Sharma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 10, 2021
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Inflammatory Bowel Diseases
|
December 22, 2023
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 18, 2020
Active Margins, Plexitis, and Granulomas Increase Postoperative Crohn's Recurrence: Systematic Review and Meta-analysis
Parul Tandon, Gurpreet Malhi, Daniyal Abdali, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 23, 2020
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysis
David M Faleck, Eugenia Shmidt, Ruiqi Huang, et al.
The American Journal of Gastroenterology
|
February 9, 2023
Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review
Sudheer K Vuyyuru, Florian Rieder, Virginia Solitano, et al.
Digestive Diseases and Sciences
|
April 29, 2023
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study
Emily C L Wong, Shahin Merat, Cristina Monaco, et al.
Journal of Crohn'S & Colitis
|
September 20, 2024
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
Sunil Samnani, Emily C L Wong, Hasan Hamam, et al.
Journal of Gastroenterology and Hepatology
|
May 21, 2021
Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysis
Neeraj Narula, Emily C L Wong, Raed AlRamdan, et al.
The American Journal of Gastroenterology
|
August 8, 2020
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial
Neeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 204) with videos related to
Sort By:
Page
of 21
Journal of the Canadian Association of Gastroenterology
|
December 16, 2024
Acceptability, feasibility, and impact of the MyGut digital health platform in the monitoring and management of inflammatory bowel disease
Jamie Zhen, Maude Simoneau, Pooja Sharma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 10, 2021
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Inflammatory Bowel Diseases
|
December 22, 2023
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 18, 2020
Active Margins, Plexitis, and Granulomas Increase Postoperative Crohn's Recurrence: Systematic Review and Meta-analysis
Parul Tandon, Gurpreet Malhi, Daniyal Abdali, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 23, 2020
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysis
David M Faleck, Eugenia Shmidt, Ruiqi Huang, et al.
The American Journal of Gastroenterology
|
February 9, 2023
Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review
Sudheer K Vuyyuru, Florian Rieder, Virginia Solitano, et al.
Digestive Diseases and Sciences
|
April 29, 2023
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study
Emily C L Wong, Shahin Merat, Cristina Monaco, et al.
Journal of Crohn'S & Colitis
|
September 20, 2024
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
Sunil Samnani, Emily C L Wong, Hasan Hamam, et al.
Journal of Gastroenterology and Hepatology
|
May 21, 2021
Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysis
Neeraj Narula, Emily C L Wong, Raed AlRamdan, et al.
The American Journal of Gastroenterology
|
August 8, 2020
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial
Neeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Page
of 21